Clinical Trial Update: Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on Troriluzole (BHV-4157) in adults with obsessive-compulsive disorder notes Phase 2 and Phase 3 studies completed and results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Troriluzole (troriluzole)

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Obsessive-Compulsive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-06-02